The Coleman Institute opens seventh location in Seattle | Addiction Professional Magazine Skip to content Skip to navigation

The Coleman Institute opens seventh location in Seattle

October 21, 2010
by Press Release
| Reprints

Richmond, VA — The Coleman Institute, nationally acclaimed for its Accelerated Detox Technique and Naltrexone implant therapy for addiction treatment, announced today that it will open its seventh US location in Seattle, Washington. The new location, led by Dr. Michael Rosenfield of Emerald City Medical Arts, will bring Dr. Peter Coleman's premier detox and addiction treatment resources to the Pacific Northwest, including the state of Washington and the greater metropolitan areas of Anchorage, Alaska and Vancouver, British Columbia, Canada. These particular areas have long been affected by controlled substance, alcohol and illicit drug abuse.

"We're all very excited about Dr. Rosenfield incorporating The Coleman Institute's services at the Seattle office," said Dr. Peter Coleman, National Medical Director and founder of The Coleman Institute. "The demand for detox and addiction treatment in the Pacific Northwest is so high that many of our patients were travelling to our San Francisco office in search of a clean, sober and better life. The commute to Seattle from areas like Anchorage, Vancouver and even throughout the state of Washington will be much easier and cost-effective for our patients."

Despite efforts to revitalize Vancouver, the city holds one of North America's highest drug addiction rates; in particular, its "Downtown Eastside" area, a 12-block residential zone, hosts nearly 40 percent of the metropolitan area's 12,000 intravenous drug users. Alaska maintains the highest per capita alcohol consumption rate in the nation, and its prevalence of alcohol dependence and abuse is twice the national average at 14 percent. The state of Washington also struggles with alcohol, heroin, cocaine and methamphetamine abuse. Emerald City Medical Arts, which will offer The Coleman Institute's detox procedures, is located in the heart of Seattle, a central point for all of the major urban areas in the Pacific Northwest.

"Dr. Coleman and I both see the need for change in this area of the country and North America," added Dr. Rosenfield. "Emerald City Medical Arts already provides Suboxone detox, so integrating The Coleman Institute's other detox procedures will be integral to providing Seattle residents with the addiction treatment they need."

Based in Richmond, Virginia, The Coleman Institute adds the Seattle, Washington office as the seventh in its list of national locations: two in California (Los Angeles and San Francisco), and one in Illinois, Indiana, Virginia and West Virginia. Emerald City Medical Arts is located at 16 Roy Street (Seattle, WA 98109) and will begin offering The Coleman Institute's services on November 1, 2010.

For more information regarding this partnership between Dr. Michael Rosenfield and The Coleman Institute, please visit